| Jun 1, 2026 | Janet Napolitano | DIRECTOR | SELL | 3.200K | $9.45 | $30K |
| Jun 1, 2026 | Brent Sabatini | SVP, CHIEF ACCOUNTING OFFICER | SELL | 379.000 | $9.45 | $4K |
| May 1, 2026 | VICKI SATO | DIRECTOR | SELL | 22.000K | $10.05 | $221K |
| Apr 6, 2026 | Vanina de Verneuil Attorney-In-Fact | PRESIDENT AND CEO | SELL | 72.559K | $9.16 | $664K |
| Apr 1, 2026 | VICKI SATO | DIRECTOR | SELL | 22.000K | $9.07 | $200K |
| Mar 23, 2026 | Brent Sabatini | SVP, CHIEF ACCOUNTING OFFICER | SELL | 7.711K | $9.12 | $70K |
| Mar 2, 2026 | VICKI SATO | DIRECTOR | SELL | 22.000K | $9.51 | $209K |
| Feb 24, 2026 | VICKI SATO | DIRECTOR | SELL-OPTIONS | — | $5.62 | $350K |
| Feb 24, 2026 | Brent Sabatini | SVP, CHIEF ACCOUNTING OFFICER | SELL | 1.430K | $9.53 | $14K |
| Feb 24, 2026 | Jason OByrne | EVP & CHIEF FINANCIAL OFFICER | SELL | 1.634K | $9.53 | $16K |
| Feb 24, 2026 | Mark Eisner | EVP AND CHIEF MEDICAL OFFICER | SELL | 3.505K | $9.69 | $34K |
| Feb 24, 2026 | Vanina Verneuil de | EVP, GENERAL COUNSEL, CORP SEC | SELL | 16.817K | $9.77 | $164K |
| Feb 24, 2026 | Vanina de Verneuil Attorney-In-Fact | CHIEF EXECUTIVE OFFICER | SELL | 14.762K | $9.53 | $141K |
| Feb 22, 2026 | Brent Sabatini | SVP, CHIEF ACCOUNTING OFFICER | GRANT | 23.171K | $7.45 | $14K |
| Feb 22, 2026 | Jason OByrne | EVP & CHIEF FINANCIAL OFFICER | GRANT | 52.911K | $7.45 | $16K |
| Feb 22, 2026 | Mark Eisner | EVP AND CHIEF MEDICAL OFFICER | GRANT | 52.911K | $7.45 | $16K |
| Feb 22, 2026 | Vanina Verneuil de | EVP, GENERAL COUNSEL, CORP SEC | GRANT | 50.555K | $7.45 | $33K |
| Feb 22, 2026 | Vanina de Verneuil Attorney-In-Fact | CHIEF EXECUTIVE OFFICER | GRANT | 265.961K | $7.45 | $142K |